Clinical trials for Central retinal vein occlusion
31 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- ENROLLING BY INVITATIONPhase 4NCT07456826Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal InjectionsHarrow Inc
- ENROLLING BY INVITATIONN/ANCT07318428AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and GlaucomaInje University
- RECRUITINGNCT07308639DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.Bayer
- RECRUITINGPhase 2NCT07259928Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein OcclusionAnnexin Pharmaceuticals AB · PI: Anna Frostegård, MD, PhD
- RECRUITINGEarly Phase 1NCT04008121Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein SodiumMediBeacon · PI: Richard B Dorshow, PhD
- RECRUITINGNCT07550777Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal BevacizumabAtaturk University
- RECRUITINGPhase 2NCT07205887A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVOEyeBiotech Ltd. · PI: Charles Miller, MD PhD
- RECRUITINGN/ANCT07002372Effect of Video Viewing on Intravitreal Injection ExperienceSecond Affiliated Hospital, School of Medicine, Zhejiang University · PI: Xiaoyun Fang, MD., PhD
- RECRUITINGPhase 2NCT06942520Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)Sierra Eye Associates
- ENROLLING BY INVITATIONNCT06511700Implementation of the Intravitreal Injection Administered by NursesCorporacion Parc Tauli
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06664502A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular DegenerationEyeBiotech Ltd.
- RECRUITINGN/ANCT06610747Home- vs Hospital-based Care of Anti-VEGF Treatment for Diabetic Macular Edema: Non-inferiority RCTZhongshan Ophthalmic Center, Sun Yat-sen University · PI: Yizhi Liu, MD, PhD
- ACTIVE NOT RECRUITINGPhase 4NCT06498050Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent Diabetic Macular EdemaGuangdong Provincial People's Hospital · PI: Honghua Yu
- RECRUITINGN/ANCT04699864Evaluation of NeoRetina Artificial Intelligence Algorithm for the Screening of Diabetic Retinopathy at the CHUMCentre hospitalier de l'Université de Montréal (CHUM) · PI: Karim Hammamji, MD
- RECRUITINGNCT06439576Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)Hoffmann-La Roche · PI: Clinical Trials
- RECRUITINGPhase 3NCT06305416A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular EdemaIncepta Pharmaceuticals Ltd · PI: Dr. Niaz Abdur Rahman
- ACTIVE NOT RECRUITINGPhase 3NCT06172257A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)Oculis · PI: Diana Do, MD
- ACTIVE NOT RECRUITINGNCT05978622Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal ImplantAbbVie · PI: ABBVIE INC.
- RECRUITINGN/ANCT05976139Micropulsed Laser in Patients With Macular Oedema in Retinal DystrophiesFondazione G.B. Bietti, IRCCS · PI: Lucia Ziccardi, MD, PhD
- ACTIVE NOT RECRUITINGNCT07106268Aqueous Humor Proteome in Retinal Vein Occlusion With Macular EdemaTianjin Medical University Eye Hospital
- ACTIVE NOT RECRUITINGPhase 1NCT06847854A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)Genentech, Inc. · PI: Clinical Trials
- ACTIVE NOT RECRUITINGNCT05476926A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology ProductsHoffmann-La Roche · PI: Clinical Trials
- ACTIVE NOT RECRUITINGNCT05607810Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)Adverum Biotechnologies, Inc. · PI: Adam Turpcu, Ph.D.
- ACTIVE NOT RECRUITINGEarly Phase 1NCT05099094VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization DiseasesShanghai BDgene Co., Ltd. · PI: Gezhi Xu, Dr
- ACTIVE NOT RECRUITINGPhase 3NCT05112861A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal DisordersOutlook Therapeutics, Inc.
- RECRUITINGNCT04935749Epidemiologic Assessment of Diabetic Retinopathy in Egypt Using Ultrawide Field Fundus PhotographsAlexandria University
- RECRUITINGPhase 3NCT04444492Combination of Ranibizumab and Targeted Laser PhotocoagulationUniversity of Giessen · PI: Matus Rehak, Professor
- RECRUITINGPhase 1NCT04187443MS-553 in Diabetic Retinopathy Patients With Central Involved Macular EdemaShenzhen MingSight Relin Pharmaceuticals Co., Ltd. · PI: Kai Zhang, MD
- RECRUITINGN/ANCT04505618Optical Coherence Tomography Angiography in Subjects With Retinal Vascular DiseaseJohns Hopkins University · PI: Amir Kashani, MD, MPH
- RECRUITINGPhase 3NCT04108156A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DMEHoffmann-La Roche · PI: Clinical Trials
- RECRUITINGN/ANCT03680794Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic RetinopathiesCHU de Reims